Litcius/Paper detail

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Ali Chour, Julie Denis, Céline Mascaux, M. Zysman, L. Bigay-Gamé, Aurélie Swalduz, V. Gounant, Alexis B. Cortot, Marie Darrason, Vincent Fallet, Édouard Auclin, Clémence Basse, Claire Tissot, C. Decroisette, P. Bombaron, Etienne Giroux‐Leprieur, L. Odier, Solenn Brosseau, Quentin Creusot, M. Gueçamburu, Corentin Meersseman, Adrien Rochand, Adrien Costantini, Claire Marine Gaillard, Eric Wasielewski, Nicolas Girard, Jacques Cadranel, Claire Lafitte, Fanny Lebossé, M. Duruisseaux

2023Journal of Thoracic Oncology72 citationsDOIOpen Access PDF

Topics & Concepts

MedicineLung cancerAdverse effectMutantOncologyLigand (biochemistry)Programmed cell deathLungTargeted therapyCancerApoptosisInternal medicineCancer researchReceptorBiochemistryGeneChemistryCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Research Studies
Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer | Litcius